Latest news
Alteogen signs $365m Hybrozyme licensing deal with pharma company - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 10:36:16 GMTAlteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTStock Splits Calendar for: - Yahoo! Finance CanadaYahoo! Finance Canada · Wed, 05 Aug 2026 06:05:42 GMT